Asthma and rhinitis control in adolescents and young adults : A real-world MASK-air study
© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd..
BACKGROUND: In allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence.
METHODS: In a cross-sectional study (2015-2022), we assessed European users of the MASK-air mHealth app of three age groups: adolescents (13-18 years), young adults (18-26 years), and adults (>26 years). We compared them on their reported rhinitis and asthma symptoms, use and adherence to rhinitis and asthma treatment and app adherence. Allergy symptoms and control were assessed by means of visual analogue scales (VASs) on rhinitis or asthma, the combined symptom-medication score (CSMS), and the electronic daily control score for asthma (e-DASTHMA). We built multivariable regression models to compare symptoms or medication accounting for potential differences in demographic characteristics and baseline severity.
RESULTS: We assessed 965 adolescent users (15,252 days), 4595 young adults (58,161 days), and 15,154 adult users (258,796 days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults.
CONCLUSIONS: Adolescents reported a better rhinitis and asthma control than young adults and adults, even though similar medication adherence levels were observed across age groups. These results pave the way for future studies on understanding how adolescents control their allergic diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology - 35(2024), 2 vom: 29. Feb., Seite e14080 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Adherence |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 15.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1111/pai.14080 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368237346 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368237346 | ||
| 003 | DE-627 | ||
| 005 | 20240215232048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240209s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pai.14080 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1294.xml |
| 035 | |a (DE-627)NLM368237346 | ||
| 035 | |a (NLM)38334246 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sousa-Pinto, Bernardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Asthma and rhinitis control in adolescents and young adults |b A real-world MASK-air study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 15.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: In allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence | ||
| 520 | |a METHODS: In a cross-sectional study (2015-2022), we assessed European users of the MASK-air mHealth app of three age groups: adolescents (13-18 years), young adults (18-26 years), and adults (>26 years). We compared them on their reported rhinitis and asthma symptoms, use and adherence to rhinitis and asthma treatment and app adherence. Allergy symptoms and control were assessed by means of visual analogue scales (VASs) on rhinitis or asthma, the combined symptom-medication score (CSMS), and the electronic daily control score for asthma (e-DASTHMA). We built multivariable regression models to compare symptoms or medication accounting for potential differences in demographic characteristics and baseline severity | ||
| 520 | |a RESULTS: We assessed 965 adolescent users (15,252 days), 4595 young adults (58,161 days), and 15,154 adult users (258,796 days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults | ||
| 520 | |a CONCLUSIONS: Adolescents reported a better rhinitis and asthma control than young adults and adults, even though similar medication adherence levels were observed across age groups. These results pave the way for future studies on understanding how adolescents control their allergic diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a adherence | |
| 650 | 4 | |a adolescents | |
| 650 | 4 | |a allergic rhinitis | |
| 650 | 4 | |a asthma | |
| 650 | 4 | |a digital health | |
| 650 | 4 | |a mHealth | |
| 650 | 4 | |a real-world data | |
| 700 | 1 | |a Valiulis, Arunas |e verfasserin |4 aut | |
| 700 | 1 | |a Melén, Erik |e verfasserin |4 aut | |
| 700 | 1 | |a Koppelman, Gerard H |e verfasserin |4 aut | |
| 700 | 1 | |a Papadopoulos, Nikolaos G |e verfasserin |4 aut | |
| 700 | 1 | |a Makela, Mika |e verfasserin |4 aut | |
| 700 | 1 | |a Haahtela, Tari |e verfasserin |4 aut | |
| 700 | 1 | |a Bonini, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Braido, Fulvio |e verfasserin |4 aut | |
| 700 | 1 | |a Brussino, Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Cruz, Alvaro A |e verfasserin |4 aut | |
| 700 | 1 | |a Fiocchi, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Giovannini, Mattia |e verfasserin |4 aut | |
| 700 | 1 | |a Gemicioglu, Bilun |e verfasserin |4 aut | |
| 700 | 1 | |a Kulus, Marek |e verfasserin |4 aut | |
| 700 | 1 | |a Kuna, Piotr |e verfasserin |4 aut | |
| 700 | 1 | |a Kupczyk, Maciej |e verfasserin |4 aut | |
| 700 | 1 | |a Kvedariene, Violeta |e verfasserin |4 aut | |
| 700 | 1 | |a Larenas-Linnemann, Désirée E |e verfasserin |4 aut | |
| 700 | 1 | |a Louis, Renaud |e verfasserin |4 aut | |
| 700 | 1 | |a Morais-Almeida, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Niedoszytko, Marek |e verfasserin |4 aut | |
| 700 | 1 | |a Ollert, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Pfaar, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Regateiro, Frederico S |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, Graham |e verfasserin |4 aut | |
| 700 | 1 | |a Samolinski, Boleslaw |e verfasserin |4 aut | |
| 700 | 1 | |a Savouré, Marine |e verfasserin |4 aut | |
| 700 | 1 | |a Taborda-Barata, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Toppila-Salmi, Sanna |e verfasserin |4 aut | |
| 700 | 1 | |a Ventura, Maria Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Vazquez-Ortiz, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Vieira, Rafael José |e verfasserin |4 aut | |
| 700 | 1 | |a Fonseca, Joao A |e verfasserin |4 aut | |
| 700 | 1 | |a Yorgancioglu, Arzu |e verfasserin |4 aut | |
| 700 | 1 | |a Zuberbier, Torsten |e verfasserin |4 aut | |
| 700 | 1 | |a Anto, Josep M |e verfasserin |4 aut | |
| 700 | 1 | |a Bousquet, Jean |e verfasserin |4 aut | |
| 700 | 1 | |a Pham-Thi, Nhân |e verfasserin |4 aut | |
| 700 | 0 | |a MASK-air think tank |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology |d 1994 |g 35(2024), 2 vom: 29. Feb., Seite e14080 |w (DE-627)NLM075107252 |x 1399-3038 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2024 |g number:2 |g day:29 |g month:02 |g pages:e14080 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pai.14080 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2024 |e 2 |b 29 |c 02 |h e14080 | ||